Living with Amyotrophic Lateral Sclerosis (ALS) presents many challenges, and changes in breathing are among the most significant. Understanding why these changes happen and how to manage them is crucial for maintaining comfort, independence, and quality of life. This article explores common respiratory challenges in ALS and the strategies used to address them.

ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. These nerve cells, called motor neurons, control voluntary muscles. As motor neurons are affected, muscles weaken over time, including those used for breathing.

Why Breathing Becomes Difficult in ALS

The muscles that help you breathe, particularly the diaphragm, can weaken as ALS progresses. This weakening makes it harder to inhale and exhale fully. Additionally, weakness in the muscles used for swallowing and coughing (often called bulbar involvement) can lead to difficulty clearing mucus and saliva, increasing the risk of chest infections.

Respiratory failure, or the inability of the lungs and breathing muscles to adequately exchange oxygen and carbon dioxide, is a major concern in ALS and a leading cause of death for most patients. However, proactive management can significantly improve this outlook.

Recognizing Respiratory Symptoms

It's important to be aware of the signs that breathing is becoming more challenging. These can include:

Shortness of breath, especially when lying down (orthopnea)
Difficulty sleeping or waking up feeling tired
Headaches in the morning
Weak cough or difficulty clearing throat
Frequent yawning or sighing
Changes in voice volume
Anxiety or difficulty concentrating

Monitoring respiratory function is a standard part of ALS care and helps the medical team determine the best time to intervene.

Key Strategies for Managing Breathing in ALS

A multidisciplinary team approach is essential for comprehensive ALS care, including managing respiratory symptoms. Your team may include neurologists, pulmonologists, respiratory therapists, speech-language pathologists, and palliative care specialists.

Here are some key strategies used to help patients breathe easier:

Non-Invasive Ventilation (NIV)

Non-invasive ventilation is a primary treatment for respiratory insufficiency in ALS. NIV provides breathing support through a mask that fits over the nose or nose and mouth, connected to a machine. It helps deliver air pressure to assist the weakened respiratory muscles.

Studies show that NIV significantly improves both life expectancy and quality of life for people with ALS once respiratory muscle weakness develops. It can help reduce symptoms like shortness of breath, improve sleep quality, and increase energy levels. While the optimal timing for starting NIV is often discussed among experts, your care team will monitor your respiratory function to recommend when it might be beneficial for you. Adherence to NIV can be improved with early introduction and careful adjustment of settings.

Airway Clearance Techniques

Weakness in cough muscles makes it difficult to clear secretions like mucus and saliva from the airways. This can lead to blockages, infections, and difficulty breathing. Techniques to help clear the airways include:

Manually Assisted Cough: A caregiver or therapist can assist the cough by applying pressure to the abdomen or chest during exhalation.
Mechanical Insufflation-Exsufflation (MIE) Devices: Often called "cough assist" devices, these machines deliver a large breath of air (insufflation) and then rapidly reverse the flow to pull air out (exsufflation), simulating a strong cough. These devices are valuable tools for preventing complications from retained secretions.

Managing Secretions and Swallowing

Difficulty managing saliva and mucus (sialorrhea) and swallowing difficulties (dysphagia) are common in ALS, particularly with bulbar involvement. These issues are linked to respiratory health because they increase the risk of aspirating (inhaling) food, liquid, or secretions into the lungs, which can lead to pneumonia.

Strategies may include:

Medications to reduce saliva production.
Working with a speech-language pathologist on swallowing techniques and diet modifications.
Considering a percutaneous endoscopic gastrostomy (PEG) tube for nutrition and medication, which can also reduce the risk of aspiration during meals.

Other Supportive Measures

Positioning: Finding comfortable positions that ease breathing, such as sleeping with the head of the bed elevated.
Exercise: While evidence is still developing and should be pursued only under medical guidance, some studies suggest exercise might potentially help maintain lung capacity and function safely in some individuals with neuromuscular conditions, though its impact on quality of life in ALS specifically is less certain.
Monitoring: Regular assessment of respiratory function using tests like Forced Vital Capacity (FVC) is essential to track changes and guide management decisions. Functional rating scales like the ALSFRS-R also incorporate respiratory assessments.

Planning Ahead

Navigating respiratory challenges in ALS also involves important conversations about future care. Discussing your wishes and goals of care with your family and healthcare team is a vital part of the process. This includes conversations about advance directives and preferences regarding life-sustaining treatments, such as long-term ventilation or tracheostomy, as part of comprehensive palliative care planning.

Conclusion

Managing respiratory symptoms is a critical component of caring for people with ALS. While the disease weakens the muscles necessary for breathing and coughing, interventions like non-invasive ventilation, mechanical cough assistance, and strategies to manage swallowing and secretions can significantly improve comfort, reduce complications, and enhance quality of life. Working closely with a dedicated multidisciplinary team ensures that you receive the most effective and personalized respiratory support throughout your journey with ALS.

References

Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999). The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). Journal of the Neurological Sciences, 169(1-2), 13–21.
Dulski, J., Konno, T., & Wszolek, Z. (1993). DCTN1-Related Neurodegeneration. In M. P. Adam, G. M. Mirzaa, R. A. Pagon, S. E. Wallace, L. J. H. Bean, K. W. Gripp, & M. J. Baker (Eds.), GeneReviews®. University of Washington, Seattle.
Georges, M., Perez, T., Rabec, C., Jacquin, L., Finet-Monnier, A., Ramos, C., Patout, M., Attali, V., Amador, M., Gonzalez-Bermejo, J., Salachas, F., & Morelot-Panzini, C. (2022). Proposals from a French expert panel for respiratory care in ALS patients. Revue Des Maladies Respiratoires, 39(6), 562–579. (Note: A similar article by the same authors appears in 2024).
Meng, L., Li, X., Li, C., Tsang, R. C. C., Chen, Y., Ge, Y., & Gao, Q. (2020). Effects of Exercise in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. American Journal of Physical Medicine & Rehabilitation, 99(8), 744–752.
Mercadante, S., & Al-Husinat, L. (2023). Palliative Care in Amyotrophic Lateral Sclerosis. Current Treatment Options in Neurology, 25(11), 345–356.
Miller, R. G., Jackson, C. E., Kasarskis, E. J., England, J. D., Forshew, D., Johnston, W., Kalra, S., Katz, J. S., Mitsumoto, H., Rosenfeld, J., Shoesmith, C., Strong, M. J., & Woolley, S. C.; Quality Standards Subcommittee of the American Academy of Neurology. (2009). Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 73(15), 1218–1226.
Morelot-Panzini, C., Bruneteau, G., & Gonzalez-Bermejo, J. (2019). NIV in amyotrophic lateral sclerosis: The 'when' and 'how' of the matter. Revue Des Maladies Respiratoires, 36(6), 693–701.
Niedermeyer, S., Murn, M., & Choi, P. J. (2019). Respiratory Failure in Amyotrophic Lateral Sclerosis. Chest, 156(6), 1228–1237.
Saccomanno, S., Saran, S., Coceani Paskay, L., De Luca, M., Tricerri, A., Mafucci Orlandini, S., Greco, F., & Messina, G. (2023). Risk factors and prevention of choking. Acta Biomedica: Atenei Parmensis, 94(S6), e2023190.
Shoesmith, C. (2023). Palliative care principles in ALS. Handbook of Clinical Neurology, 199, 185–197.
Silva, I. S., Pedrosa, R., Azevedo, I. G., Forbes, A.-M., Fregonezi, G. A. F., Dourado Junior, M. E., Lima, S. R., & Ferreira, G. M. (2019). Respiratory muscle training in children and adults with neuromuscular disease. The Cochrane Database of Systematic Reviews, 12(12), CD011704.
Soriani, M.-H., & Desnuelle, C. (2017). Care management in amyotrophic lateral sclerosis. Revue Neurologique, 173(10), 621–628.
Swash, M. (2024). Timing initiation of non-invasive ventilation in management of ALS. Current Opinion in Neurology, 37(1), 126–129.
Urushitani, M., Warita, H., Atsuta, N., Izumi, Y., Kano, O., Shimizu, T., Nakayama, Y., Narita, Y., Nodera, H., Fujita, T., Mizoguchi, K., Morita, M., & Aoki, M.; Japanese Society of Neurology. (2024). The clinical practice guideline for the management of amyotrophic lateral sclerosis in Japan-update 2023. International Journal of Molecular Sciences, 25(3), 1460.
Wijesekera, L. C., & Leigh, P. N. (2009). Amyotrophic lateral sclerosis. Orphanet Journal of Rare Diseases, 4, 3.
Witzel, S., Maier, A., Steinbach, R., Grosskreutz, J., Koch, J. C., Sarikidi, A., Petri, S., Günther, R., Wolf, J., Hermann, A., Prudlo, J., Cordts, I., Lingor, P., Löscher, W. N., Kohl, Z., Hagenacker, T., Ruckes, C., Koch, B., Spittel, S., Günther, K., ... German Motor Neuron Disease Network (MND-NET). (2022). Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis. JAMA Neurology, 79(12), 1214–1224.

Breathing Easier: Managing Respiratory Symptoms in ALS